Compare StocksECL vs PFE

Ecolab Inc. (ECL) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-09-17, ECL is overvalued at $274, with a DCF intrinsic value of $182 and a margin of safety of -50%. PFE is overvalued at $28, with an intrinsic value of $22 and a margin of safety of -23%. Of the two, PFE has the wider margin of safety.

ECL
Ecolab Inc.
$274.12
VS
PFE
Pfizer Inc.
$27.66

Rewards

ECL
  • Ecolab Inc. scores 71/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 21.0% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $2.39 of earning power — management is an exceptional capital allocator.
PFE
  • Gross margin of 74.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Insiders have bought $3.0M worth of stock in the past 3 months — significant skin in the game.

Risks

ECL
  • FCF yield of 1.9% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • PEG ratio of 2.48 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $7.2M worth of stock in the past 3 months — significant insider liquidation.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • FCF yield of 7.9% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 12.68 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
ECL
PFE
Valuation
$1.47B
Free Cash Flow
$12.49B
1.92%
FCF Yield
7.92%
36.79
Trailing P/E
36.40
29.11
Forward P/E
9.55
Quality & Moat
10.27%
ROIC
9.42%
21.96%
ROE
5.01%
44.21%
Gross Margin
74.72%
2.48
PEG Ratio
12.68
Balance Sheet Safety
0.87
Net Debt / Equity
0.61
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
2.04
1.07%
Dividend Yield
6.26%
ECL: 3Ties: 3PFE: 6
ECLPFE

Historical Fundamentals

Learn more →
ECL

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ECL
$9.25
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$3.53B
Δ Market Cap
+$32.62B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ECL
27.4% Overvalued
Price is 27.4% above estimated fair value
Current Price: $274.12
Fair Value: $215.16
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
23.3% Overvalued
Price is 23.3% above estimated fair value
Current Price: $27.66
Fair Value: $22.43
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ECL

What growth rate is the market pricing in at $274?

+17.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +22.3%

The market implies +17.6% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +22.3%, reflecting ongoing growth investment.

PFE

What growth rate is the market pricing in at $28?

+6.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +5.3%

The market implies +6.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +5.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ECL
71/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ECL
-2.50
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ECL
Insiders 0.2%Institutions 94.1%Retail & Other 5.7%
No. of Institutional Holders2,309
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.1%Retail & Other 30.8%
No. of Institutional Holders3,645
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ECL
1
Buys (3M)
6
Buys (12M)
Total value (12M): $3.93M
GREEN ERIC MARK
Director
$1.02M
@ $276.64 · 2026-09-11
CLARK BENJAMIN M.
Officer
$263,831
@ $263.83 · 2026-06-11
DOUKERIS MICHEL
Director
$2.00M
@ $258.00 · 2026-06-10
MACLENNAN DAVID W
Director
$250,650
@ $250.65 · 2026-05-13
MACLENNAN DAVID W
Director
$205,530
@ $256.91 · 2026-05-04
MACLENNAN DAVID W
Director
$193,198
@ $257.60 · 2025-12-08
MACLENNAN DAVID W
Director
$167,108
@ $278.51 · 2025-08-13
MACLENNAN DAVID W
Director
$125,872
@ $251.74 · 2025-05-07
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
3
Buys (3M)
3
Buys (12M)
Total value (12M): $2.96M
BOURLA ALBERT
Chief Executive Officer
$1.00M
@ $26.34 · 2026-08-12
BLAYLOCK RONALD E
Director
$998,821
@ $25.46 · 2026-08-05
BUCKLEY MORTIMER J.
Director
$960,369
@ $25.52 · 2026-08-05
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ECL
3
Sells (3M)
13
Sells (12M)
Total value (12M): $27.15M
BECK CHRISTOPHE
Chief Executive Officer
$5.00M
@ $280.14 · 2026-08-18
COOK GREGORY B
Officer
$1.30M
@ $285.15 · 2026-08-11
KIRKLAND SCOTT D.
Chief Financial Officer
$929,755
@ $276.96 · 2026-07-30
BROWN DARRELL R
Officer
$2.61M
@ $260.89 · 2026-06-09
VAUTRINOT SUZANNE M.
Director
$266,040
@ $264.98 · 2026-05-27
COOK GREGORY B
Officer
$1.07M
@ $304.25 · 2026-02-26
MCKIBBEN TRACY B.
Director
$390,455
@ $308.66 · 2026-02-25
BECK CHRISTOPHE
Chief Executive Officer
$6.15M
@ $307.37 · 2026-02-24
ALFANO NICHOLAS J
Officer
$2.88M
@ $303.58 · 2026-02-17
REICH VICTORIA J
Director
$301,080
@ $301.08 · 2026-02-13
BRADWAY JENNIFER J
Officer
$185,132
@ $302.01 · 2026-02-13
DE BOO ALEXANDER A
Officer
$381,452
@ $268.25 · 2025-11-24
BECK CHRISTOPHE
Chief Executive Officer
$5.68M
@ $261.41 · 2025-11-12
VAUTRINOT SUZANNE M.
Director
$383,401
@ $283.16 · 2025-08-19
BRADWAY JENNIFER J
Officer
$225,379
@ $279.28 · 2025-08-13
REICH VICTORIA J
Director
$352,300
@ $271.00 · 2025-06-12
COOK GREGORY B
Officer
$565,202
@ $253.00 · 2025-05-15
ALFANO NICHOLAS J
Officer
$2.52M
@ $253.75 · 2025-05-07
BERGER LARRY L
Chief Technology Officer
$2.90M
@ $266.95 · 2025-02-26
BRADWAY JENNIFER J
Officer
$228,866
@ $267.37 · 2025-02-25
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
2
Sells (12M)
Total value (12M): $134,661
DAMICO JENNIFER B.
Officer
$83,261
@ $25.40 · 2026-08-05
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ECL
FearGreed
😐Neutral(48/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(60/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ECL
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (48)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (60)
View ECL Full AnalysisView PFE Full Analysis

Frequently Asked Questions: ECL vs PFE

Is Ecolab Inc. or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a -23.3% margin of safety (intrinsic value $22 vs. price $28), compared to ECL's -50.4% margin of safety (intrinsic $182 vs. $274).

Which stock has a wider economic moat, Ecolab Inc. or Pfizer Inc.?

ECL scores 71/100 (Wide moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer Inc. in financial distress?

PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. ECL scores 4.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Ecolab Inc. or Pfizer Inc.?

Pfizer Inc. (PFE) generates a 7.9% free cash flow yield, compared to Ecolab Inc.'s 1.9%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Ecolab Inc. or Pfizer Inc.?

ECL earns 10.3% ROIC versus PFE's 9.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Ecolab Inc.'s or Pfizer Inc.'s?

ECL's dividend earns a safety score of 94/100 (Very Safe), compared to PFE's 24/100 (Unsafe). ECL has raised its dividend for 3 consecutive years.